185 related articles for article (PubMed ID: 38135175)
21. Pulmonary arterial hypertension in the setting of scleroderma is different than in the setting of lupus: A review.
Bazan IS; Mensah KA; Rudkovskaia AA; Adonteng-Boateng PK; Herzog EL; Buckley L; Fares WH
Respir Med; 2018 Jan; 134():42-46. PubMed ID: 29413506
[TBL] [Abstract][Full Text] [Related]
22. Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trial.
Coghlan JG; Galiè N; Barberà JA; Frost AE; Ghofrani HA; Hoeper MM; Kuwana M; McLaughlin VV; Peacock AJ; Simonneau G; Vachiéry JL; Blair C; Gillies H; Miller KL; Harris JHN; Langley J; Rubin LJ;
Ann Rheum Dis; 2017 Jul; 76(7):1219-1227. PubMed ID: 28039187
[TBL] [Abstract][Full Text] [Related]
23. [Clinical analysis of 79 pulmonary arterial hypertension cases from 1892 connective tissue disease patients].
Lei YX; Zhang X; Cui Y; Dong GF; Luo RQ
Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(41):2934-7. PubMed ID: 20137654
[TBL] [Abstract][Full Text] [Related]
24. Predictors of Long-term Outcomes in Patients With Connective Tissue Disease Associated With Pulmonary Arterial Hypertension.
Nakayama K; Nakajima Y; Tanaka R; Hirata KI; Emoto N
J Clin Rheumatol; 2021 Dec; 27(8):e371-e377. PubMed ID: 32511146
[TBL] [Abstract][Full Text] [Related]
25. [Recommendations for the diagnosis and treatment of connective tissue disease associated pulmonary arterial hypertension in China].
Zhang X; Zhao JL; Ding F; Yang J; Wang J; Zeng XF; Zhao Y
Zhonghua Nei Ke Za Zhi; 2022 Nov; 61(11):1206-1216. PubMed ID: 36323561
[TBL] [Abstract][Full Text] [Related]
26. Recommendations for screening and detection of connective tissue disease-associated pulmonary arterial hypertension.
Khanna D; Gladue H; Channick R; Chung L; Distler O; Furst DE; Hachulla E; Humbert M; Langleben D; Mathai SC; Saggar R; Visovatti S; Altorok N; Townsend W; FitzGerald J; McLaughlin VV;
Arthritis Rheum; 2013 Dec; 65(12):3194-201. PubMed ID: 24022584
[TBL] [Abstract][Full Text] [Related]
27. Selexipag for the treatment of connective tissue disease-associated pulmonary arterial hypertension.
Gaine S; Chin K; Coghlan G; Channick R; Di Scala L; Galiè N; Ghofrani HA; Lang IM; McLaughlin V; Preiss R; Rubin LJ; Simonneau G; Sitbon O; Tapson VF; Hoeper MM
Eur Respir J; 2017 Aug; 50(2):. PubMed ID: 28818881
[TBL] [Abstract][Full Text] [Related]
28. Pulmonary hypertension in connective tissue diseases: an update.
Aithala R; Alex AG; Danda D
Int J Rheum Dis; 2017 Jan; 20(1):5-24. PubMed ID: 28205373
[TBL] [Abstract][Full Text] [Related]
29. [The clinical analysis of pulmonary arterial hypertension in connective tissue disease].
Ji YQ; Zhang ZL; Lu WX
Zhonghua Nei Ke Za Zhi; 2006 Jun; 45(6):467-71. PubMed ID: 16831323
[TBL] [Abstract][Full Text] [Related]
30. Pulmonary arterial hypertension associated with connective tissue diseases: A review focusing on distinctive clinical aspects.
Kato M; Atsumi T
Eur J Clin Invest; 2018 Feb; 48(2):. PubMed ID: 29285766
[TBL] [Abstract][Full Text] [Related]
31. Epidemiology and mortality of connective tissue disease-associated pulmonary arterial hypertension: A national cohort study in taiwan.
Lin CY; Ko CH; Hsu CY; Chen HA
Semin Arthritis Rheum; 2020 Oct; 50(5):957-962. PubMed ID: 32906031
[TBL] [Abstract][Full Text] [Related]
32. Right atrial function for the prediction of prognosis in connective tissue disease-associated pulmonary arterial hypertension: a study with two-dimensional speckle tracking.
Bai Y; Yang J; Liu J; Ning H; Zhang R
Int J Cardiovasc Imaging; 2019 Sep; 35(9):1637-1649. PubMed ID: 31037473
[TBL] [Abstract][Full Text] [Related]
33. [Clinical analysis of pulmonary arterial hypertension secondary to connective tissue disease in children].
Xing Y; Song HM; Wu XY; He YY; Wei M
Zhonghua Er Ke Za Zhi; 2008 Nov; 46(11):822-6. PubMed ID: 19099898
[TBL] [Abstract][Full Text] [Related]
34. Scleroderma pulmonary arterial hypertension: the same as idiopathic pulmonary arterial hypertension?
Khan SL; Mathai SC
Curr Opin Pulm Med; 2023 Sep; 29(5):380-390. PubMed ID: 37461869
[TBL] [Abstract][Full Text] [Related]
35. [Pulmonary arterial hypertension in connective tissue disease].
Cottin V
Rev Mal Respir; 2006 Sep; 23(4 Suppl):13S61-72. PubMed ID: 17057632
[TBL] [Abstract][Full Text] [Related]
36. Pulmonary arterial hypertension related to connective tissue disease: a review.
Ahmed S; Palevsky HI
Rheum Dis Clin North Am; 2014 Feb; 40(1):103-24. PubMed ID: 24268012
[TBL] [Abstract][Full Text] [Related]
37. Riociguat for the treatment of pulmonary arterial hypertension associated with connective tissue disease: results from PATENT-1 and PATENT-2.
Humbert M; Coghlan JG; Ghofrani HA; Grimminger F; He JG; Riemekasten G; Vizza CD; Boeckenhoff A; Meier C; de Oliveira Pena J; Denton CP
Ann Rheum Dis; 2017 Feb; 76(2):422-426. PubMed ID: 27457511
[TBL] [Abstract][Full Text] [Related]
38. Serum uric acid is associated with disease severity and may predict clinical outcome in patients of pulmonary arterial hypertension secondary to connective tissue disease in Chinese: a single-center retrospective study.
Wang J; Wang Y; Li X; Huang Y; Sun X; Wang Q; Zhang M
BMC Pulm Med; 2020 Oct; 20(1):272. PubMed ID: 33076877
[TBL] [Abstract][Full Text] [Related]
39. Pulmonary arterial hypertension (PAH) in connective tissue diseases.
Kähler CM; Colleselli D
Rheumatology (Oxford); 2006 Oct; 45 Suppl 3():iii11-3. PubMed ID: 16987822
[TBL] [Abstract][Full Text] [Related]
40. Characteristics and Survival of Anti-U1 RNP Antibody-Positive Patients With Connective Tissue Disease-Associated Pulmonary Arterial Hypertension.
Sobanski V; Giovannelli J; Lynch BM; Schreiber BE; Nihtyanova SI; Harvey J; Handler CE; Denton CP; Coghlan JG
Arthritis Rheumatol; 2016 Feb; 68(2):484-93. PubMed ID: 26415038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
